Zenith Drugs approves sale of land and building for Rs 13.75 crore

Board & Shareholder Meetings View source PDF Explain this filing

ZENITHDRUG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.0%Reaction day

₹40.00

prior close

₹38.80

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%-3.2% vs market

On the reaction day the stock moved 3.2 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-3.0+0.2-3.2

Next day

-1.5+0.9-2.4

+0.0-0.8+0.8

+3.5-0.1+3.6

-2.5-1.7-0.8

-4.5-4.3-0.2

-1.4-7.5+6.1

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zenith Drugs board approved sale of its 5-hectare land and building at Industrial Park Mohana, Indore, to M/s ACE Engineering & Chemicals for Rs 13.75 crore. Property contributes 0% to turnover but represents about 18.57% of net worth. Sale deed to be executed by Oct 20, 2026, with payment expected by Nov 20, 2026. Transaction is not a related party deal.

Likely market impact

Asset sale worth about 18.57% of net worth; proceeds expected by Nov 20, 2026 may strengthen cash position.